Clinical observation on treatment of acute hemorrhagic stroke by tianhuang huoxue tongluo decoction.
- Author:
Hui LIAO
1
;
Dan-ping LI
;
Jie XU
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Aged; Cerebral Hemorrhage; complications; drug therapy; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Male; Middle Aged; Phytotherapy; Secondary Prevention; Stroke; drug therapy; etiology
- From: Chinese Journal of Integrated Traditional and Western Medicine 2004;24(8):698-700
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the clinical effect of Tianhuang Huoxue Tongluo Decoction (THTD) in treating acute hemorrhagic stroke.
METHODSSeventy-two patients were randomly divided into the treated group (n = 32) and the control group (n = 40), they were treated with conventional Western medicine treatment and to the patients in the treated group, THTD was given additionally starting from the 6th day of disease for 30 days.
RESULTSComparison of the neurofunction deficit scoring on the 15th day and the 30th day after treatment was significantly different in both group (P < 0.05). The markedly improving rate in the treated group was 71.88%, which was better than that in the control group (55.00%, P < 0.05), and no relaptic hemorrhage or secondary infarction case was found in the treated group.
CONCLUSIONTHTD may have bi-directional regulation on coagulation mechanism and fibrinolysis promoting mechanism, thus to benefit the resolving and absorption of hematoma in stroke patients, which plays important role in preventing relapse and secondary infarction, raising the cure rate, reducing mortality and disability rate.
